1. Incubation of mitochondria from heart, liver and kidney with [32P]phosphate allowed 32p incorporation into two intramitochondrial proteins, the decarboxylase a-subunit of the pyruvate dehydrogenase complex (mol.wt. 42000) and a protein of mol.wt. 48000.2. This latter protein incorporated 32p more slowly than did pyruvate dehydrogenase, was not precipitated by antibody to pyruvate dehydrogenase and showed behaviour distinct from that of pyruvate dehydrogenase towards high-speed centrifugation and pyruvate dehydrogenase phosphate phosphatase. 3. 32p incorporation into the protein was greatly diminished by the presence of 0.1 mM-4-methyl-2-oxopentanoate, but enhanced by pyruvate (1 mM), hypo-osmotic treatment of mitochondria and, under some conditions, by uncoupler. 4. The activity of branched-chain 2-oxo acid dehydrogenase was assayed in parallel experiments. Under appropriate conditions the enzyme was inhibited when 32p incorporation was increased and activated when incorporation was decreased. The data suggest that the 48 000-mol.wt. phosphorylated protein is identical with the decarboxylase subunit of branched-chain 2-oxo acid dehydrogenase and that this enzyme may be controlled by a phosphorylation-dephosphorylation cycle akin to that for pyruvate dehydrogenase. 5. Strict correlation between activity and 32p incorporation was not observed, and a scheme for the regulation of the enzyme is proposed to account for these discrepancies.
1. Incubation of mitochondria from heart, liver and kidney with [32P] phosphate allowed 32p incorporation into two intramitochondrial proteins, the decarboxylase a-subunit of the pyruvate dehydrogenase complex (mol.wt. 42000) and a protein of mol.wt. 48000.2. This latter protein incorporated 32p more slowly than did pyruvate dehydrogenase, was not precipitated by antibody to pyruvate dehydrogenase and showed behaviour distinct from that of pyruvate dehydrogenase towards high-speed centrifugation and pyruvate dehydrogenase phosphate phosphatase. 3. 32p incorporation into the protein was greatly diminished by the presence of 0.1 mM-4-methyl-2-oxopentanoate, but enhanced by pyruvate (1 mM), hypo-osmotic treatment of mitochondria and, under some conditions, by uncoupler. 4. The activity of branched-chain 2-oxo acid dehydrogenase was assayed in parallel experiments. Under appropriate conditions the enzyme was inhibited when 32p incorporation was increased and activated when incorporation was decreased. The data suggest that the 48 000-mol.wt. phosphorylated protein is identical with the decarboxylase subunit of branched-chain 2-oxo acid dehydrogenase and that this enzyme may be controlled by a phosphorylation-dephosphorylation cycle akin to that for pyruvate dehydrogenase. 5. Strict correlation between activity and 32p incorporation was not observed, and a scheme for the regulation of the enzyme is proposed to account for these discrepancies.
The metabolism of the branched-chain amino acids valine, isoleucine and particularly leucine may play an important role in the regulation of protein synthesis and breakdown (see Fulks et al., 1975; Buse & Reid, 1976; Goldberg & Chang, 1978; Chua et al., 1979) . The primary event in the catabolism of these three amino acids is their cytoplasmic transamination to the respective keto acids followed by transport of these keto acids into the mitochondria. Intramitochondrial oxidative decarboxylation to the relevant CoA derivative (see Meister, 1965; Odessey & Goldberg, 1979 ) is catalysed by a single multienzyme complex, the branched-chain 2-oxo acid dehydrogenase, which, like pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase, utilizes lipoamide and thiamin pyrophosphate as cofactors (Parker & Randle, 1978a,b; Pettit et al., 1978; Danner et al., 1979) . As a reaction involving a Abbreviation used: SDS, sodium dodecyl sulphate. * Present address: Unilever Research, Colworth Laboratory, Colworth House, Sharnbrook, Bedford MK44 ILQ, U.K. Vol. 196 considerable decrease in Gibbs energy, like that catalysed by pyruvate dehydrogenase, it represents a committed step in the catabolic pathway and thus is a likely candidate for regulation. Indeed, the enzyme from liver, kidney and heart is susceptible to similar end-product inhibition by CoA derivatives and NADH to that observed with pyruvate dehydrogenase (Parker & Randle, 1978a,b; Denton et al., 1975) . Moreover, there is indirect evidence to suggest that the enzyme from heart and skeletal muscle may be inhibited by phosphorylation (Parker & Randle, 1978c Odessey & Goldberg, 1979) . However, direct demonstration of phosphate incorporation into the enzyme complex has not been reported, and there is no evidence for the control of the enzyme from kidney and liver by phosphorylation (Parker & Randle, 1978c Pettit et al., 1978) .
In the present paper we show that in isolated liver, kidney and heart mitochondria [32Plphosphate may be incorporated into an intramitochondrial protein of mol.wt. 48 000 that has the properties of a subunit of the branched-chain 2-oxo acid dehydrogenase complex. It is demonstrated that an increase in phosphorylation may lead to inhibition, whereas dephosphorylation may activate the enzyme. However, a strict correlation of 32p incorporation with enzyme activity is not always observed. Various effectors of the phosphorylation system are described and related to a proposed scheme for the regulation of the enzyme. A preliminary account of some of these results has been published (Hughes & Halestrap, 1980) .
Experimental

Materials
Female albino Wistar rats (body wt. 225-275g) were allowed free access to food and water and were killed by decapitation. Unless otherwise stated the sources of all chemicals, biochemicals and radiochemicals were as given in Halestrap (1975) and . Antiserum was raised in a sheep against purified pig heart pyruvate dehydrogenase complex by Dr. R. J. Mayer, University of Nottingham, Nottingham, U.K. (titre 15 units/ml of antiserum). For details of the specificity of the antibody and its general use see .
Preparation ofmitochondria
Mitochondria from rat heart, liver and kidney cortex were prepared in 300 mM-sucrose/2 mm-EGTA/lOmM-Tris/HCl buffer, pH 7.5, as described previously (Halestrap, 1975) . For kidney-cortex and heart mitochondria tissue disruption was achieved by using a Polytron PT 10 homogenizer (lOs, setting 3) and the extraction medium was gupplemented with 10mg of bovine serum albumin/ ml. All mitochondrial preparations used showed respiratory control ratios of greater than 3 with succinate as substrate.
Incubation and extraction ofmitochondria
Incubations of mitochondria both for 32P incorporation into mitochondrial proteins and for enzyme-activity measurements were conducted in parallel experiments with identical media and conditions. Mitochondria (2-4 mg of protein) were added to 0.5 ml of medium containing MgCl2 ( mM), potassium phosphate (0.5 mM), potassium succinate (5 mM), potassium EGTA (1 mM), Tris/HCl (20mM) addition of trichloroacetic acid (final concn. 10%, w/v) and separation of the denatured protein by centrifugation. The protein pellet was then washed once with lml of 0.2M-NaCl. For measurement of enzyme activity and some 32P-radioactivity measurements where 32P-labelled native protein was required, the incubation mixture was transferred to plastic centrifuge tubes and the mitochondria were rapidly sedimented by centrifugation at 9000g for 30s in an Eppendorf 3200 centrifuge. The supernatant was immediately removed, and the pellet was frozen in liquid N2 and stored at -700C. Control experiments demonstrated that neither 32p incorporation nor the activities of branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase were appreciably altered during this separation procedure. The pellet was subsequently extracted for enzyme assay, antibody treatment and other studies by using 250,u1 of medium containing potassium phosphate (100mM), potassium EDTA (5mM), KF (20mM), dithiothreitol (3mM), rat serum (I00,ul/ml) and Triton X-100 (0.5%, w/v). To complete mitochondrial disruption, freezing and thawing were performed twice. The activities of branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase remained stable for several hours at 0°C in this medium.
Enzyme assays
Citrate synthase and pyruvate dehydrogenase activities and mitochondrial protein concentrations were assayed as described previously (Cooper et al., 1974) . Citrate synthase was used as a routine correction for any variation in extraction efficiency between experiments. Branched-chain 2-oxo acid dehydrogenase was assayed spectrophotometrically at 370C essentially as described by Parker & Randle (1978c) . The medium contained 30mM-potassium phosphate, 3 mM-2-mercaptoethanol, 2 mM-MgCl2, 0.4 mM-CoA, 0.4 mM-thiamin pyrophosphate, 1 mm-NAD+ and 2mM-KCN. After addition of mitochondrial extract (100l1 to 2ml of medium), the background rate of NADH production was measured before addition of 0.25mM-3-methyl-2-oxobutyrate to initiate the enzyme reaction. The initial rate of absorbance change was used to calculate enzyme activity, progressive inhibition of the reaction occurring after 1-2min as described by Parker & Randle (1978c) . Similar reaction rates were observed when 3-methyl-2-oxopentanoate was used as substrate, but the curve in the trace was more pronounced, perhaps reflecting more effective end-product inhibition (Parker & Randle, 1978a,b) .
Addition of excess lipoamide dehydrogenase, as suggested by Pettit et al. (1978) , was without effect on the assay.
The maximal activities of the enzyme, obtained after incubation of mitochondria with 4-methyl-46i) Phosphorylation of branched-chain 2-oxo acid dehydrogenase 2-oxopentanoate (0.1 mM) or uncoupler at high osmolarity (see below), were (in munits/mg of protein at 37°C) for liver mitochondria 6.7±0.4 (34), for kidney mitochondria 11.7+2.1 (9) and for heart mitochondria 4.7 + 0.6 (9). All values are expressed as the means + S.E.M. for the numbers of separate mitochondrial preparations shown in parentheses. These values are in good agreement with those obtained by others (Pettit et al., 1978; Parker & Randle, 1978c Danner et al., 1979) , when the temperature of the assay is taken into account.
Separation and detection of [32Plphosphoproteins
Routine separation of proteins was performed as described previously by using discontinuous SDS/polyacrylamide-gel electrophoresis in 1 cm tracks on 10% (w/v) slab gels (14cm x 14cm) with the solutions described by Laemmli (1970) . Samples for analysis, whether acidprecipitated proteins or antibody pellets, were dissolved in stacking-gel buffer, containing SDS (40mg/ml), sucrose (200mg/ml), Bromophenol Blue (0.2 mg/ml) and 100 mM-2-mercaptoethanol, by heating at 1000C for 5min. Electrophoresis was performed at 200C for 2-3 h at 40 mA/slab.
After electrophoresis, the gel was washed for 1 h in 1 M-trichloroacetic acid in 50% (v/v) methanol to precipitate proteins in the gel. Protein was detected by staining with Coomassie Blue, and the gels were laid on cellophan and dried on boards under vacuum. The dried gels were exposed to Kodak Kodirex KT X-ray film for 2-7 days. If an increased sensitivity was required, intensifier screens were used in combination with Kodak X-Omat X-ray film (Laskey & Mills, 1977) . The radioautographs were scanned at 630nm with a Gilford spectrophotometer linked to a Hewlett Packard 9845S computer. Exposure of the film was such that peak heights did not exceed an absorbance of 1.0. The peak height and area were measured from a base-line, which was taken as the lowest reading of absorbance on that track. (Fig. 1 ).
Expression ofresults
With heart mitochondria and to a smaller extent those from liver and kidney, the 48 000-mol.wt. protein was clearly resolved only when mitochondria were also exposed to pyruvate [scans (ii) and (iii) in Figs. 1(a), 1(b) and 1(c)] to activate pyruvate dehydrogenase and thus diminish its 32p incorporation (Cooper et al., 1974) . The presence of pyruvate also appeared to enhance labelling of the 48000-mol.wt. protein in all three types of mitochondria ( Fig. 1) . Pyruvate was added in all the experiments described below unless otherwise stated. This allowed clear resolution of the 48000-mol.wt. peak in all three mitochondrial preparations ( . In kidney mitochondria an additional intramitochondrial phosphorylated protein of mol.wt. 80000 was observed that was not present in other mitochondrial preparations (Fig. lb) .
In all three mitochondrial preparations addition of 4-methyl-2-oxopentanoate (0.1-0.5 mM) to the incubation greatly decreased or abolished the labelling of the 48 000-mol.wt. protein while having little or no effect on the labelling of pyruvate dehydrogenase ( Fig. 1 ). This specific effect of 4-methyl-2-oxopentanoate, a substrate of the branched-chain 2-oxo acid dehydrogenase, suggests that the identity of the 48 000-mol.wt. protein might be that of a phosphorylated subunit of the enzyme. In addition, it is known that the decarboxylase subunit has a molecular weight of about 46000 (Pettit et al., 1978) . Further experiments were conducted to confirm this identification.
The branched-chain 2-oxo acid dehydrogenase is located exclusively within the mitochondria (Odessey & Goldberg, 1979) Preparation and incubation of (a) liver mitochondria, (b) kidney mitochondria and (c) heart mitochondria were as described in the Experimental section. In each case mitochondria were incubated for 15 min in the presence (ii and iii) or in the -absence (i) of 1mM-pyruvate, In (iii) 0.5mM-4-methyl-2-oxopentanoate was also added. In all cases proteins from equivalent samples were separated by SDS/polyacrylamide-slab-gel electrophoresis. The dye front (Bromophenol Blue) was allowed to migrate 10cm. (d) Results from a similar but separate experiment in which kidney (i), liver (ii) and heart (iii) mitochondria were incubated in the presence of pyruvate as in condition (ii) of (a), (b) and (c) and the proteins were resolved on the same gel. In (b) the molecular weights of the three peaks, determined by using bovine serum albumin (mol.wt.
of ADP (results not shown). After solubilization of the mitochondrial proteins with Triton X-100 as described in the Experimental section, centrifugation for 20min at room temperature in a Beckman Airfuge (100000g approx.) sedimented both pyruvate dehydrogenase (> 90%) and branched-chain 2-oxo acid dehydrogenase (>80%) activities, and both radioactive proteins were also found almost totally in the pellet. Shorter centrifugation (5min) was sufficient to sediment most (>80%) of the pyruvate dehydrogenase activity but little (<30%) of the branched-chain 2-oxo acid dehydrogenase activity, and this was reflected in the differential behaviour of the two 32P-labelled proteins (Fig. 2b) . The parallel behaviour of the 32P-labelled proteins and enzyme activities strengthens the evidence that the 42000-mol.wt. and 48000-mol.wt. proteins are the phosphorylated subunits of pyruvate dehydrogenase and the branched-chain 2-oxo acid dehydrogenase respectively, and is consistent with the known molecular weights and hydrodynamic properties of the two complexes (Hayakawa et al., 1966; Barrera et al., 1972; Linn et al., 1972; Pettit et al., 1978) . Incubation of mitochondrial extracts with specific antibody to pyruvate dehydrogenase led to precipitation of all the 42000-mol.wt. protein but none of the 48 000-mol.wt. protein (Fig. 2c) . Parallel experiments showed that antibody precipitated and inactivated pyruvate dehydrogenase, but was without effect on branched-chain 2-oxo acid dehydrogenase activity. Similarly incubation of mitochondrial extracts with pyruvate dehydrogenase phosphate phosphatase activated pyruvate dehydrogenase and all radioactivity was lost from the 42 000-mol.wt. protein (Fig. 2a) . Little or no decrease in the 48 000-mol.wt. peak was observed, however, and there was no appreciable activation of branchedchain 2-oxo acid dehydrogenase. This contrasts with the data of Parker & Randle (1980) , who observed activation of the enzyme with pyruvate dehydrogenase phosphate phosphatase, but these workers incubated their system in the absence of Triton X-100 and fluoride, which were used in the present experiments.
Thus the behaviour of this 48000-mol.wt. phosphoprotein of heart, liver and kidney mitochondria is distinct from that of the 42000-mol.wt. subunit of pyruvate dehydrogenase. The evidence suggests that it is a phosphorylated subunit of the branched-chain 2-oxo acid dehydrogenase. Furthermore twodimensional gel electrophoresis (isoelectric focusing followed by SDS/polyacrylamide-gel electro-68 000), lactate dehydrogenase (mol.wt. 36 500) and lysozyme (mol.wt. 14 500) as standards, are given. In (c) the insert shows the two major peaks on an expanded (x 5) absorbance scale. phoresis) showed that the labelled protein was identical in all three types of mitochondria and the same as the 48 000-mol.wt. protein labelled in mitochondria of intact adipocytes .
Relationships between activity and phosphorylations ofbranched-chain 2-oxo acid dehydrogenase Studies were conducted to discover the optimal conditions of 32P-labelling of the 48 000-mol.wt. protein in an attempt to correlate activity and 32p incorporation into the enzyme. A variety of incubation conditions for the mitochondria were used to monitor any effect on the activity of the extracted branched-chain 2-oxo acid dehydrogenase complex.
The time course of 32p incorporation into the 48 000-mol.wt. protein is shown in Fig. 3 In Fig. 4 Fig. 3 . Incubations of mitochondria with 32p1 were for 15min and the osmolarity was varied with sucrose. Mitochondrial volumes (A) were measured in a separate experiment as described by Halestrap & McGivan (1979) .
Under similar conditions the effects of changing the osmolarity on the activity of branched-chain 2-oxo acid dehydrogenase were studied in the presence and in the absence of uncoupler and 4-methyl-2-oxopentanoate (Fig. 5) . It has already been stated that pyruvate (1 mM) was present throughout to make the experiment comparable with the 32P-labelling experiments, and, as indicated below, this also serves to diminish the basal enzyme activity. As the osmolarity increased the basal enzyme activity also increased, and to a limited degree this correlated with the decrease in labelling observed in Fig. 4 . The presence of 4-methyl-2-oxopentanoate (0.1mM) led to activation at all osmolarities, in parallel with a decease in 32P incorporation. The effect of uncoupler on the activity of branched-chain 2-oxo acid dehydrogenase was complex. As the osmolarity increased from 100 to 200mosm the activity of the enzyme decreased, whereas at higher osmolarities the activity began to increase again. It is worth noting that pyruvate dehydrogenase was fully activated by uncoupler under all these conditions. Two important points emerge from these studies. Firstly, under iso-osmotic conditions (about 300mosM) little if any activation of branched-chain 2-oxo acid dehydrogenase is observed in the presence of 4-methyl-2-oxopentanoate (0.1 mM) or uncoupler. This may explain the inability of Parker & Randle (1978c to demonstrate control of the liver and kidney enzyme various effectors Preparation and incubation of liver mitochondria were as described in the Experimental section. Intact mitochondria were incubated for 15min in the absence (i) or in the presence of 0.1 mM-(ii) or 0.5 mM-(iii) 4-methyl-2-oxopentanoate, with 1 mmdichloracetate (iv) or with 2pM-carbonyl cyanide p-trifluoromethoxyphenylhydrazone (v). In each case proteins from the acid-precipitated pellet were separated by SDS/polyacrylamide-slab-gel electrophoresis. The dye front (Bromophenol Blue) was allowed to migrate 1Ocm. Vol. 196 by phosphorylation and dephosphorylation. Secondly, uncoupler, which might be expected to activate the. enzyme by decreasing mitochondrial ATP and so decreasing phosphorylation, only does so under conditions of high osmolarity, and may even inhibit at low osmolarity. Under these latter conditions 32P-labelling experiments (Fig. 6) show that 32p incorporation into pyruvate dehydrogenase is abolished whereas that into the 48 000-mol.wt. protein is actually increased. Again 32p incorporation and activity measurements correlate, albeit in an unexpected way. Fig. 6 also demonstrates that dichloroacetate decreases 32p incorporation into both proteins, and this also correlates with an increase in branched-chain 2-oxo acid dehydrogenase activity (see Table 1 ). Similar results (Table 1) could be observed with heart and kidney mitochondria at low osmolarity (150mosM).
The activating effect of 4-methyl-2-oxopentanoate (0.1 mM) on branched-chain 2-oxo acid dehydrogenase activity agrees well with the data of Parker & Randle (1978c for heart mitochondria. However, we were unable to detect an effect of 3-methyl-2-oxobutyrate (0.1 or 0.5mM) on either enzyme activity or 32P-labelling, whereas Parker & Randle (1978c) do report activation of the heart enzyme by this effector. In addition, when higher concentrations of the 4-methyl-2-oxopentanoate were used (0.2-0.5mM) results became extremely variable, and frequently inhibition of activity was seen, especially at high osmolarity (see Table 1 ). Thus, in liver mitochondria incubated at 150mosM, 0.1 mM-4-methyl-2-oxopentanoate caused an activation of the enzyme to 165 + 16% of the control value (mean + S.E.M. for 19 separate incubations) whereas at 300mosm the activity was decreased to 74+3% (n = 10) by 0.5 mM-4-methyl-2-oxopentanoate. For kidney mitochondria the changes in activity as percentages of the control values were 143 + 13% (n = 6) and 74 + 2% (n = 4) respectively, and for heart mitochondria 234 ± 70% (n = 5) and 65 ± 6% (n = 4) respectively. However, at all concentrations of 4-methyl-2-oxopentanoate, 32p incorporation into the 48 000-mol.wt. protein was greatly diminished. Proposed scheme To account for the observed results a scheme (Scheme 1) can be proposed and further tested. The fundamental propositions of the scheme are that the kinase is inhibited by 4-methyl-2-oxopentanoate and dichloroacetate, but is relatively insensitive to inhibition by ADP in comparison with pyruvate dehydrogenase kinase (Linn et al., 1969) . The phosphatase activity is assumed to be low, and to be inhibited by conditions favouring end-product inhibition. In this respect the activity of the phosphatase may differ from the activity of pyruvate dehydro- Table 1 . Activity of branched-chain 2-oxo acid dehydrogenase in liver, kidney and heart mitochondria incubated under various conditions Mitochondria were incubated with the additions shown for 15 min and then extracted for measurement of enzyme activities as described in the Experimental section. Osmolarity was altered with KCl. All values were corrected for variable extraction efficiency by using citrate synthase activities as described in the Experimental section. For liver mitochondria three experiments are shown on different preparations of mitochondria to demonstrate the variation in actual activities but similarity of trends between experiments. Similar additional experiments performed on kidney and heart mitochondria also showed variation in actual values but similarity of trends between experiments. The uncoupler used was carbonyl cyanide p-trifluoromethoxyphenylhydrazone.
Activity of branched-chain 2-oxo acid dehydrogenase (munits/mg of protein) in mitochondria from Liver Kidney Heart
Additions to incubation mixture I 150 mosM+ pyruvate (1.0mM) genase phosphatase towards pyruvate dehydrogenase, whose end products, with the possible exception of NADH (Pettit et al., 1975) , have no observed effect on dephosphorylation (Pettit et al., 1975; Denton et al., 1975) . Pyruvatp dehydrogenase kinase, on the other hand, is activated under conditions of end-product inhibition, and a change in the conformation of pyruvate dehydrogenase is a likely explanation of this effect (Pettit et al., 1975; Cooper et al., 1975; Cate & Roche, 1978) . Such a conformational change of the branched-chain 2-oxo acid dehydrogenase by end-product inhibition could similarly affect the affinity of the phosphorylated form of this enzyme towards its phosphatase. To account for the effects of osmolarity on "P incorporation and enzyme activity, it is proposed that the phosphatase is a separate entity from the enzyme complex, as discussed above.
The activation of enzyme activity by 0.1 mM-4-methyl-2-oxopentanoate may be explained by inhibition of the kinase allowing a rise in the concentration of active dephosphorylated complex. However, inhibition of activity observed at high concentrations of 4-methyl-2-oxopentanoate may be explained by the metabolism of the acid to the branched-chain acyl-CoA derivative, which is known to accumulate in mitochondria under similar conditions Walajtys-Rode et al., 1979) . Such conditions of end-product inhibition would lead to inhibition of the phosphatase and hence to inhibition of enzyme activity, as well as inhibition of the kinase by 4-methyl-2-oxopentanoate (diminished 3"P-labelling seen). Incorporation of 32p would be far displaced from a true steady state under these conditions, and could account for the decreased enzyme activity accompanied by decreased 32p incorporation.
The inhibitory effects of uncoupler under some conditions might be explained by activation of pyruvate dehydrogenase, causing an elevation of acetyl-CoA through increased pyruvate oxidation. This would decrease the free CoA concentration and thus inhibit the phosphatase. The kinase would continue to function, since it is relatively insensitive to inhibition by ADP. As the osmolarity increases and the volume decreases, enhanced phosphatase activity (see above) would allow activation of the enzyme to be observed.
To test this hypothesis further, additional experiments reported in Table 1 were performed. It can be seen that in the presence of pyruvate, which would be expected to increase acetyl-CoA at the expense of free CoA, the enzyme is considerably less active than in the absence of pyruvate. Addition of uncoupler in the presence of pyruvate caused an inhibition of the enzyme that could be partially relieved by L-carnitine (1 mM). Addition of acetyl-DL-carnitine in place of L-carnitine had the reverse effect. Since carnitine might be expected to liberate free CoA but acetylcarnitine to utilize it to produce acetyl-CoA, the results are consistent with inhibition of branched-chain 2-oxo acid dehydrogenase under conditions of low free CoA concentrations. Fig. 1 . This confirms that the phosphatase is extremely inactive under these conditions and that Scheme 1 may allow understanding of the relationship between activity and phosphorylation of branched-chain 2-oxo acid dehydrogenase. Vol. 196 General conclusions
The data reported in this paper demonstrate that, when incubated under suitable conditions, and especially with hypo-osmotic buffers in the presence of pyruvate, liver, heart and kidney mitochondria phosphorylate an intramitochondrial protein of mol.wt. 48000 in addition to pyruvate dehydrogenase. The protein can be distinguished from pyruvate dehydrogenase by its different behaviour towards pyruvate dehydrogenase phosphate phosphatase, antibody to pyruvate dehydrogenase and high-speed centrifugation. The phosphorylation of the protein is greatly inhibited by the presence of 4-methyl-2-oxopentanoate (0.1 mM), which suggests that it may be identified as the branched-chain 2-oxo acid dehydrogenase. This enzyme is known to be exclusively mitochondrial (see Odessey & Goldberg, 1979) and to have a decarboxylase subunit of mol.wt. about 48000 (Pettit et al., 1978) . The molecular weight and hydrodynamic properties of the enzyme complex (Pettit et al., 1978; Danner et al., 1979) are also compatible with the sedimentation of the phosphorylated protein after high-speed centrifugation for 20min in a Beckman Airfuge. Data from various laboratories have provided indirect evidence for inactivation of this enzyme in heart mitochondria by phosphorylation, which may be inhibited by 4-methyl-2-oxopentanoate (Parker & Randle, 1978c Odessey & Goldberg, 1979) . We have confirmed these observations, and demonstrated the parallel activation of the enzyme and inhibition of 32p incorporation into the 48 000-mol.wt. protein. Parker & Randle (1978c have suggested that the enzymes from kidney and liver mitochondria are not regulated in this manner. Clearly the data in the present paper refute this suggestion. Furthermore the results indicate that the branched-chain 2-oxo acid dehydrogenase dephosphorylation-phosphorylation system differs in some respects from the pattern observed for pyruvate dehydrogenase. To account for the type of behaviour seen with uncoupler, high concentrations of 4-methyl-2-oxopentanoate and different osmotic strengths, a scheme was put forward and tested experimentally (see above for discussion of Scheme 1).
The proposed scheme for the regulation of the branched-chain 2-oxo acid dehydrogenase not only accounts for the data in the present paper, but also explains many published observations on the metabolism of branched-chain amino acids and 2-oxo acids in mitochondria and intact tissue preparations. Thus the inhibitory effects of branchedchain acylcarnitines, pyruvate and uncoupler and the activating effect of carnitine on oxidation of branched-chain 2-oxo acids by intact heart, liver and skeletal-muscle mitochondria (Bremer & Davis, 1978 ; Van Hinsbergh et al., 1979) all comply with the proposed scheme. Similarly, in the perfused heart the activation of leucine and branched-chain 2-oxo acid oxidation by dichloroacetate and the inhibition by pyruvate and ketone bodies. (Buffington et al., 1979; Sans et al., 1980a,b) can be explained by the model. Dichloroacetate could act by inhibition of the kinase, and pyruvate and ketone bodies could cause inhibition of the phosphatase by decreasing the free CoA. Lund (1978) has suggested that free CoA may also be important in regulating leucine catabolism in the liver. Williamson et al. (1979) reached similar conclusions by showing that pyruvate and fatty acids inhibited 4-methyl-2-oxobutyrate oxidation by hepatocytes, but stressed that end-production inhibition by NADH may be more important. Measurement of short-chain and medium-chain acyl-CoA showed that the branched-chain 2-oxo acid dehydrogenase was the site of inhibition. In freeze-clamped liver we have been unable to observe any appreciable activity of the dehydrogenase, suggesting that in vivo the enzyme may be largely inhibited. This correlates with the enhanced labelling of the protein seen in intact fat-cells and liver cells (A. Vargas & A. P. Halestrap, unpublished work) when compared with isolated mitochondria.
Whether the enzyme can be regulated hormonally through changes in phosphorylation similarly to pyruvate dehydrogenase remains to be established. Frick & Goodman (1980) have reported some activation of the enzyme by insulin in adipose tissue through a decrease in the Km of the enzyme for 2-oxo acids rather than by an increase in Vmax.. A large stimulation by insulin of leucine and 4-methyl-2-oxopentanoate oxidation by starved rat hindquarters has also been reported (Hutson et al., 1980) , although slight inhibition was observed in fed animals. Starvation also appears to cause an increase in the activity of the enzyme in skeletal muscle and kidney (Goldberg & Odessey, 1972; Adibi et a!., 1974) , and induction of the liver enzyme is caused by amino acids (Wohlhueter & Harper, 1970) . However, these effects are long-term effects and may represent an increase in total enzyme activity rather than changes in the phosphorylation state of the enzyme (Wohlhueter & Harper, 1970) .
Both leucine and 4-methyl-2-oxopentanoate cause an increase in protein synthesis and a decrease in protein degradation in heart and muscle (see Chua et al., 1979) . Thus any regulation of the branchedchain 2-oxo acid dehydrogenase, the rate-limiting step in muscle leucine catabolism (Odessey & Goldberg, 1979) , could have far-reaching consequences in protein metabolism. The demonstration of a phosphorylation-dephosphorylation cycle of t4e enzyme in all tissues studied provides an obvious mechanism for such regulation.
Note added in proof (received 8 January 1981) Since the writing of the present paper there have been three reports in the literature that support the results presented here. Odessey (1980a) has provided further indirect evidence for a regulatory phosphorylation-dephosphorylation cycle of branched-chain 2-oxo acid dehydrogenase activity from liver, kidney and heart mitochondria. In agreement with our own observations, he found that the enzyme from kidney and liver was almost fully active (dephosphorylated) in isolated mitochondria, whereas that from heart was largely in the inactive (phosphorylated) form. Inactivation of the enzyme required the splitting of the y-phosphate group of ATP. He has subsequently shown that 32p may be incorporated into the kidney enzyme from [y_32p]_ ATP (Odessey, 1980b) . Waymack et al. (1980) have demonstrated a substantial and rapid decrease in branched-chain 2-oxo acid dehydrogenase in the perfused heart exposed to pyruvate. This effect required the transport of pyruvate into the mitochondria and supports the inhibitory effects of pyruvate observed in our own experiments.
